Puyu Shi

Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment

Puyu Shi, You-Take Oh, Guojing Zhang et al. · Cancer Letters · 2016 · 181 citations

Lung Cancer Treatment, Systems Biology, Oncogenic Agent +9

Overcoming Acquired Resistance to AZD9291, A Third-Generation EGFR Inhibitor, through Modulation of MEK/ERK-Dependent Bim and Mcl-1 Degradation

Puyu Shi, You-Take Oh, Liang Deng et al. · Clinical Cancer Research · 2017 · 140 citations · Full text

LncRNA MALAT1 Depressed Chemo-Sensitivity of NSCLC Cells through Directly Functioning on miR-197-3p/p120 Catenin Axis.

Yang Tian, Hong Li, Tianjun Chen et al. · Europe PMC (PubMed Central) · 2019 · 74 citations · Full text

Differentially expressed glycosylated patterns of α-1-antitrypsin as serum biomarkers for the diagnosis of lung cancer

Yiqian Liang, Tianran Ma, Asmitananda Thakur et al. · Glycobiology · 2014 · 73 citations · Full text

Glycobiology, Immunology, Pathology +17

miRNA-204 suppresses human non-small cell lung cancer by targeting ATF2

Shuo Zhang, Lei Gao, Asmitananda Thakur et al. · Tumor Biology · 2016 · 45 citations